Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - water for injection - solvent for parenteral use - . - solvents and diluting agents, incl. irrigating solutions

Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - human plasma protein - solution for injection - 250 international unit(s)/millilitre - specific immunoglobulins; tetanus immunoglobulin

Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - c1 esterase inhibitor (human) - powder and solvent for solution for injection - 1500 international unit(s) - c1-inhibitor, plasma derived

Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - c1 esterase inhibitor (human) - powder and solvent for solution for injection - 2000 international unit(s) - c1-inhibitor, plasma derived

Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - c1 esterase inhibitor (human) - powder and solvent for solution for injection - 3000 international unit(s) - c1-inhibitor, plasma derived

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - water for injections, quantity: 40 ml - injection, solution - excipient ingredients: - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - water for injections, quantity: 20 ml - injection, solution - excipient ingredients: - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - fibrinogen, quantity: 900 mg - injection, powder for - excipient ingredients: sodium citrate; albumin; arginine hydrochloride; sodium chloride - treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenaemia and hypofibrinogenaemia.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

csl behring gmbh - water for injection 2 ml - solvent for parenteral use - 2 ml - water for injection 2 ml - solvents and diluting agents, incl. irrigating solutions

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

csl behring gmbh - water for injection 2 ml - solvent for parenteral use - 3 ml - water for injection 3 ml - solvents and diluting agents, incl. irrigating solutions